• Citer

Central pathology laboratory review of HER2 and ER in early breast cancer: An ALTTO trial [BIG 2-06/NCCTG N063D (Alliance)] ring study

par McCullough, Ann A.E.;Dell'Orto, Patrizia;Reinholz, Monica;Gelber, Richard;Dueck, Amylou A.C.;Russo, Leila;Jenkins, Robert R.B.;Andrighetto, Stefania;Chen, Beiyun;Jackisch, Christian;Untch, Michael;Perez, Edith A;Piccart-Gebhart, Martine ;Viale, Giuseppe
Référence Breast cancer research and treatment, 143, 3, page (485-492)
Publication Publié, 2014-02

Article révisé par les pairs

• Accès en ligne
• Détails
• Contenu
• Statistiques

Titre:	Central pathology laboratory review of HER2 and ER in early breast cancer: An ALTTO trial [BIG 2-06/NCCTG N063D (Alliance)] ring study
Auteur:	McCullough, Ann A.E.; Dell'Orto, Patrizia; Reinholz, Monica; Gelber, Richard; Dueck, Amylou A.C.; Russo, Leila; Jenkins, Robert R.B.; Andrighetto, Stefania; Chen, Beiyun; Jackisch, Christian; Untch, Michael; Perez, Edith A; Piccart-Gebhart, Martine; Viale, Giuseppe
Informations sur la publication:	Breast cancer research and treatment, 143, 3, page (485-492)
Statut de publication:	Publié, 2014-02
Sujet CREF:	Cancérologie
Mots-clés:	Breast cancer
	Central laboratory review
	Estrogen receptor testing
	HER2 testing
	Local versus central laboratory concordance
MeSH keywords:	Antibodies, Monoclonal, Humanized -- administration & dosage
	Breast Neoplasms -- drug therapy -- genetics -- pathology
	Early Detection of Cancer
	Estrogen Receptor alpha -- genetics -- metabolism
	Female
	Humans
	Immunohistochemistry
	In Situ Hybridization, Fluorescence
	Italy
	Quinazolines -- administration & dosage
	Receptor, ErbB-2 -- genetics -- metabolism
	Tumor Markers, Biological -- genetics
Note générale:	SCOPUS: ar.j
Langue:	Anglais
Identificateurs:	urn:issn:0167-6806
	info:doi/10.1007/s10549-013-2827-0
	info:scp/84894073975
	info:pmid/24395109
	PMC4039190